Cargando…
Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer
The poor prognosis for patients with inflammatory breast cancer (IBC) compared to patients with other types of breast cancers emphasizes the need to better understand the molecular underpinnings of this disease with the goal of developing effective targeted therapeutics. Dysregulation of matriptase...
Autores principales: | Zoratti, Gina L., Tanabe, Lauren M., Hyland, Thomas E., Duhaime, Michael J., Colombo, Éloïc, Leduc, Richard, Marsault, Eric, Johnson, Michael D., Lin, Chen-Yong, Boerner, Julie, Lang, Julie E., List, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295421/ https://www.ncbi.nlm.nih.gov/pubmed/27528224 http://dx.doi.org/10.18632/oncotarget.11262 |
Ejemplares similares
-
Targeting matriptase in breast cancer abrogates tumor progression via impairment of stromal-epithelial growth factor signaling
por: Zoratti, Gina L., et al.
Publicado: (2015) -
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met
por: Mueller, Kelly L, et al.
Publicado: (2012) -
Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1
por: List, Karin, et al.
Publicado: (2003) -
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
por: Szabo, Roman, et al.
Publicado: (2011) -
Cell Surface Human Airway Trypsin‐Like Protease Is Lost During Squamous Cell Carcinogenesis
por: Duhaime, Michael J., et al.
Publicado: (2016)